<i>In situ</i> excitation of BODIPY fluorophores by <sup>89</sup>Zr-generated Cerenkov luminescence-Reference-Cited by-同舟云学术

In situ excitation of BODIPY fluorophores by ⁸⁹Zr-generated Cerenkov luminescence

Published:2022 Issue:83 Volume:58 Page:11689-11692
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Gristwood Katie¹,Luli Saimir²,Rankin Kenneth S.³,Knight James C.¹^ORCID

Affiliation:

1. School of Natural and Environmental Sciences, Faculty of Science, Agriculture and Engineering, Newcastle University, Newcastle Upon Tyne, NE1 7RU, UK

2. Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle, Newcastle Upon Tyne, NE2 4HH, UK

3. Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK

Abstract

Secondary Cerenkov-induced fluorescence imaging (SCIFI) is an emerging optical imaging modality that affords high signal-to-noise images. This report examines the utility of BODIPY fluorophores in SCIFI applications using 89Zr-generated Cerenkov luminescence.

Funder

Engineering and Physical Sciences Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2022/CC/D2CC03875G

Reference28 articles.

1. Quantitative imaging of disease signatures through radioactive decay signal conversion

2. Intraoperative 68Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study

3. Dosimetry for FLASH Radiotherapy: A Review of Tools and the Role of Radioluminescence and Cherenkov Emission

4. Photodynamic Therapy Using Cerenkov and Radioluminescence Light

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and In Vitro Evaluation of a HER2-Specific ImmunoSCIFI Probe;ACS Omega;2023-12-07